Mark Thursz

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection
    Mark Thursz
    Gastroenterology and Hepatology Research, Imperial College St Mary's Hospital Campus, Norfolk Place, London W2 1NY, UK
    Gut 56:613-4. 2007
  2. ncbi Understanding the host genetics of chronic hepatitis B and C
    Mark Thursz
    Hepatology and Gastroenterology Section, Department of Medicine, Imperial College, London, United Kingdom
    Semin Liver Dis 31:115-27. 2011
  3. ncbi Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis
    Arvind Sangwaiya
    Department of Gastroenterology, Ealing Hospital NHS Trust, London, UK
    Eur J Gastroenterol Hepatol 23:721-4. 2011
  4. ncbi NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west London
    Patrick T F Kennedy
    Department of Hepatology, Imperial College London at St Mary s Hospital, London, UK
    Antivir Ther 13:1067-76. 2008
  5. ncbi Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimation
    Mark Wright
    Hepatology Section, Faculty of Medicine, Imperial College, London W2 1NY, UK
    Liver Int 23:28-34. 2003
  6. ncbi Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection
    Simon Hellier
    The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Hepatology 38:1468-76. 2003
  7. ncbi Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha
    Armin Luik
    University of Mainz, Department of Medicine, 55101 Mainz, Germany
    J Interferon Cytokine Res 24:585-93. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection
    Mark Thursz
    Gastroenterology and Hepatology Research, Imperial College St Mary's Hospital Campus, Norfolk Place, London W2 1NY, UK
    Gut 56:613-4. 2007
  2. ncbi Understanding the host genetics of chronic hepatitis B and C
    Mark Thursz
    Hepatology and Gastroenterology Section, Department of Medicine, Imperial College, London, United Kingdom
    Semin Liver Dis 31:115-27. 2011
    ..Indeed, stratification of clinical trial populations based on IL-28B genotype is already considered mandatory...
  3. ncbi Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis
    Arvind Sangwaiya
    Department of Gastroenterology, Ealing Hospital NHS Trust, London, UK
    Eur J Gastroenterol Hepatol 23:721-4. 2011
    ..However, the precise link between hepcidin levels and iron absorption in HFE-H patients has been poorly understood...
  4. ncbi NICE guidelines and a treatment algorithm for the management of chronic hepatitis B: a review of 12 years experience in west London
    Patrick T F Kennedy
    Department of Hepatology, Imperial College London at St Mary s Hospital, London, UK
    Antivir Ther 13:1067-76. 2008
    ....
  5. ncbi Quantitative versus morphological assessment of liver fibrosis: semi-quantitative scores are more robust than digital image fibrosis area estimation
    Mark Wright
    Hepatology Section, Faculty of Medicine, Imperial College, London W2 1NY, UK
    Liver Int 23:28-34. 2003
    ..Accurate determination of a threshold greyscale level representing fibrous tissue is critical. This method has not been fully evaluated in clinical practice...
  6. ncbi Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection
    Simon Hellier
    The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Hepatology 38:1468-76. 2003
    ..018, OR: 2.29, 95% CI: 1.14-4.58). In conclusion, our study suggests a possible role of the polymorphisms CCR5-delta32, RANTES -403, and MCP-2 Q46K in the outcome of HCV infection...
  7. ncbi Autoregulatory role of interleukin-10 in hepatitis C patients treated with IFN-alpha
    Armin Luik
    University of Mainz, Department of Medicine, 55101 Mainz, Germany
    J Interferon Cytokine Res 24:585-93. 2004
    ..This suggests an autoregulatory role of IL-10 in IFN therapy...